Titus B. Ball - 01 Sep 2026 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Reporting relationship: Principal Accounting Officer
Issuer ticker: ONC
Reported as of: 01 Sep 2026
Net transaction value: -$46,974
SEC form: 4
Accepted by SEC: 03 Sep 2026, 17:17:16 UTC
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Frank Collazo, as Attorney-in-Fact

Key filing fact

Titus B. Ball filed Form 4 for BeOne Medicines Ltd. (ONC) on 03 Sep 2026.

Key facts

This page summarizes Titus B. Ball's Form 4 filing for BeOne Medicines Ltd. (ONC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Sep 2026, 17:17.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: -$46,974.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001675628 Primary reporting owner

Ball Titus B.

Relationship: Principal Accounting Officer
Address: C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND
Signature: /s/ Frank Collazo, as Attorney-in-Fact
Signature date: 03 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONC transaction

American Depositary Shares

Sale

Transaction value: $46,974
Shares: -132
Change %: -100%
Price: $355.86
Shares after: 0
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F1, F2

ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 97,929
Date: 01 Sep 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each American Depositary Share represents 13 Ordinary Shares.

Footnote F2

The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of August 31, 2023, subject to continued service.